IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma

IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma

The therapeutic armamentarium of metastatic Renal Cell Carcinoma (mRCC) has consistently expanded in recent years, with the introduction of VEGF/VEGFR (Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor) inhibitors, mTOR (mammalian Target Of Rapamycin) inhibitors and Immu...

Full description

Bibliographic Details
Main Authors:	Mimma Rizzo, Luca Varnier, Gaetano Pezzicoli, Marta Pirovano, Laura Cosmai, Camillo Porta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Oncology
Subjects:	IL-8 biomarker of resistance anti-angiogenic agent immune checkpoint inhibitors kidney cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.990568/full

Similar Items

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma
by: Stephane Oudard, et al.
Published: (2021-12-01)

Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
by: Marion Ferreira, et al.
Published: (2021-06-01)

Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence
by: Mimma Rizzo, et al.
Published: (2017-08-01)

bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti‐angiogenic agent apatinib combination therapy
by: Gehan Xu, et al.
Published: (2022-10-01)

Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
by: Ella Barkan, et al.
Published: (2023-02-01)

Cisplatin-based chemotherapy for the treatment of metastatic collecting duct carcinomas: A real-world, retrospective analysis
by: Mimma Rizzo, et al.
Published: (2022-10-01)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
by: Brigida Anna Maiorano, et al.
Published: (2022-10-01)

Leveraging the synergy between anti-angiogenic therapy and immune checkpoint inhibitors to treat digestive system cancers
by: Qinlan Xu, et al.
Published: (2024-12-01)

Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
by: Xiaomi Li, et al.
Published: (2022-12-01)

Tumor cell density dependent IL-8 secretion induces the fluctuation of tregs/CD8 + T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpoint
by: Mengchao Yan, et al.
Published: (2023-03-01)

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment
by: Jian Xu, et al.
Published: (2024-11-01)

Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients
by: Xiaohong Xie, et al.
Published: (2023-08-01)

Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
by: Luka Roškar, et al.
Published: (2021-12-01)

Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
by: An‐Qi Li, et al.
Published: (2024-01-01)

Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia
by: Shah Nawaz, et al.
Published: (2023-12-01)

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
by: Lars M. Schiffmann, et al.
Published: (2022-05-01)

Functionalized nanoceria exhibit improved angiogenic properties
by: Nethi, Susheel Kumar, et al.
Published: (2020)

A therapy inactivating the tumor angiogenic factors
by: Cristian Morales-Rodrigo
Published: (2012-11-01)

Metabolic Syndrome and its Part in Angiogenic Cochleovestibulopathy Development
by: N. I. Ukhankova
Published: (2012-06-01)

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
by: Changyu Yao, et al.
Published: (2023-01-01)

An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential
by: Nurul Akmaryanti Abdullah, et al.
Published: (2021-02-01)

Sensitivity analysis unveils the interplay of drug-sensitive and drug-resistant Glioma cells: Implications of chemotherapy and anti-angiogenic therapy
by: Latifah Hanum, et al.
Published: (2024-01-01)

Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
by: Chiara Bazzichetto, et al.
Published: (2022-10-01)

Metamorphic Effect of Angiogenic Switch in Tumor Development: Conundrum of Tumor Angiogenesis Toward Progression and Metastatic Potential
by: Daniel Leon Moshe, et al.
Published: (2023-07-01)

Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia
by: Kristina Kumer, et al.
Published: (2018-10-01)

Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review
by: Irina Sandra, et al.
Published: (2022-09-01)

Radiogenomics Monitoring in Breast Cancer Identifies Metabolism and Immune Checkpoints as Early Actionable Mechanisms of Resistance to Anti-angiogenic Treatment
by: Shaveta Mehta, et al.
Published: (2016-08-01)

VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases
by: Amanda Louise White, et al.
Published: (2023-04-01)

Anti-Angiogenic/Anxiolytic Effect of Chlordiazepoxide: Evidence on Dual Activity for Cancer Patients
by: Reza Yarani, et al.
Published: (2011-09-01)

Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series
by: Mimma Rizzo, et al.
Published: (2024-07-01)

Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer
by: Danming He, et al.
Published: (2023-10-01)

Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
by: Hanwool Jeon, et al.
Published: (2023-02-01)

Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration
by: Amanda Acevedo-Jake, et al.
Published: (2021-11-01)

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
by: Lei Wang, et al.
Published: (2024-01-01)

The inhibition of protein translation promotes tumor angiogenic switch
by: Hui Luo, et al.
Published: (2022-06-01)

Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer
by: Luka Roškar, et al.
Published: (2022-11-01)

Significance of anti-angiogenic therapy in head and neck cancer—Heterogeneity of tumor endothelium
by: Kyoko Hida, et al.
Published: (2010-02-01)

Resistance to immune checkpoint inhibitors in the treatment of metastatic renal cancer
by: A. A. Izmailov, et al.
Published: (2023-09-01)

The Effect of Turmeric Decoctum to the Angiogenic Molecules Expression on Chicken Embryo
by: Sultanah Zahariah, et al.
Published: (2017-04-01)

Effect of anti-angiogenic drugs along with chemotherapy in breast cancer treatment: review article
by: Najibeh Nasiri, et al.
Published: (2019-07-01)